Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Change in Inventory (2017 - 2019)

Ironwood Pharmaceuticals' Change in Inventory history spans 7 years, with the latest figure at $451000.0 for Q3 2019.

  • For Q3 2019, Change in Inventory rose 261.65% year-over-year to $451000.0; the TTM value through Dec 2020 reached $934000.0, changed N/A, while the annual FY2020 figure was -$648000.0, N/A changed from the prior year.
  • Change in Inventory for Q3 2019 was $451000.0 at Ironwood Pharmaceuticals, down from $483000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $768000.0 in Q1 2018 and bottomed at -$1.0 million in Q2 2017.
  • The 4-year median for Change in Inventory is $152000.0 (2019), against an average of $140181.8.
  • The largest annual shift saw Change in Inventory tumbled 100.32% in 2015 before it skyrocketed 1181.69% in 2018.
  • A 4-year view of Change in Inventory shows it stood at -$4000.0 in 2015, then skyrocketed by 18475.0% to $735000.0 in 2017, then plummeted by 87.35% to $93000.0 in 2018, then surged by 384.95% to $451000.0 in 2019.
  • Per Business Quant, the three most recent readings for IRWD's Change in Inventory are $451000.0 (Q3 2019), $483000.0 (Q2 2019), and $152000.0 (Q1 2019).